Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.
Related Posts
Drug lords face federal charges in New York after transferred from Mexican prison
A notorious Mexican drug lord pleaded not guilty to several federal charges in New York on Friday. 72-year-old Rafael Caro…
Actor’s death sparks discussion about toxic online comments
Kim Sae-ron, 24, was found dead by a friend at her home in Seoul on Sunday.
Inside Afghanistan more than 3 years after U.S. withdrawal
The United Nations warned that President Trump’s freeze on humanitarian aid will hit Afghan women especially hard. An official said…